Health Affairs, 26, no. 3 (2007): 715 doi: 10.1377/hlthaff.26.3.715 © 2007 by Project HOPE	New Online   Pay Cuts For Medicare Docs   Access To Care Woes   Public Coverage More Efficient   Empowering Consumers

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Related Collections Consumer Issues

Individual Level

PROLOGUE

Risk-Benefit Information At The Individual Level

In July 2002, American women and their health care providers faced a large-scale, surprise test of their ability to communicate, comprehend, and apply risk-benefit information at the individual level. Results from the Women’s Health Initiative (WHI) trials of postmenopausal hormone therapy showed that at the population level, the risks of combined estrogen-progesterone hormone replacement therapy (HRT) exceeded its benefits. WHI participants taking HRT were told to stop; those taking estrogen only were not. Each of the estimated six million American women on HRT was advised to have a "serious talk" with her doctor to determine if, in her case, benefits . . . [Full Text of this Article]

                      What's this?